You just read:

Cantargia: Combined Directed Issue and Fully Guaranteed Rights Issue of 232 MSEK for Its Expanded Clinical Program of Immuno-oncology Antibody CAN04

News provided by

Cantargia AB

09 Nov, 2017, 18:58 GMT